For some cancers, especially hematologic pathologies, transplanting frozen-thawed ovarian tissue can transfer malignant cells. This paper overviews this risk for different cancers.
When performing ovarian stimulation for fertility preservation in cancer patients it is critical to understand time constraints, potential complications, risks, and the limited time opportunity.
We discuss the basis for the growing use of AMH in assessment of the ovarian reserve across the lifespan, and its emerging role in assessment before and after cancer treatment.
Pregnancies achieved after cryopreservation of in vitro and in vivo matured oocytes are not associated with adverse pregnancy outcomes and may represent a novel strategy of fertility preservation.
Among 87,403 infertile women, IVF was not significantly associated with breast or gynecologic cancers. Among women receiving four or more cycles, ovarian cancer was nonsignificantly elevated, supporting further risk monitoring.
In cryopreserved semen from men with newly diagnosed cancer, all specimens show severe decline in postthaw total motile sperm count, with most severe reductions in the myeloid leukemia group.
Reflections on “Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation”
Cancer does not influence ovarian response in controlled ovarian hyperstimulation for fertility preservation.
Important medical conditions associated with Klinefelter syndrome (KS) are categorized as: 1) motor, cognitive, and behavioral dysfunction; 2) tumors; 3) vascular disease; and 4) endocrine/metabolic and autoimmune diseases. Earlier diagnosis of KS may lead to earlier intervention with effective treatment.
Measures of ovarian reserve are impaired among cancer survivors compared with unexposed females of similar age. The degree of impairment is dependent on the toxicity of the previous treatment.
Women with malignant disease have a significantly lower oocyte retrieval rate compared with agematched healthy controls; specific malignancy or stage effect on ovarian response to stimulation cannot be assessed.
The third polycystic ovary syndrome (PCOS) consensus report summarizes current knowledge and identifies knowledge gaps regarding various women’s health aspects of PCOS.
Female cancer survivors who have received systemic therapy have lower pregnancy and live birth rates and a relatively high risk for cycle cancellation in ART compared with other infertility patients.
High intra-age, intercycle, and intercenter variation in oocyte aneuploidy was observed in first polar body chromosome analysis of oocyctes.
In a large series, we confirmed that the ovarian response to controlled ovarian hyperstimulation in cancer patients is lower than expected for their age compared with a historical control.
Fertility & Sterility Discussion Forums